Summary
The a2 Milk Company (NZX:ATM) reported FY26 results for the year ended 30 June 2026: group revenue rose 12.4 percent year on year to NZD 1.9749 billion, EBITDA was NZD 284.4 million and NPAT was NZD 207.5 million. By region, China and other Asia revenue grew 11.2 percent, Australia and New Zealand (ANZ) rose 10.2 percent and US revenue increased 28.6 percent. In a broadly flat China market, infant formula grew 5 percent, other nutritionals rose 42 percent and liquid milk increased 22 percent.
Underlying EBITDA grew 5.4 percent, slower than reported sales growth, reflecting second-half supply chain disruption and cost pressure.
Commentary
a2 Milk Company's FY26 result shows 5 percent growth in a broadly flat China infant formula market, with other nutritionals and liquid milk up 42 percent and 22 percent respectively, reflecting brand resilience and category expansion. As one of New Zealand's largest dairy companies by market value, a2's A2 protein differentiation gives it a distinct niche in China's premium segment, but China still accounts for more than 50 percent of revenue, leaving it heavily reliant on a single market. US growth of 28.6 percent is fast but off a small base, and competition in US liquid milk is intense, so a2 will need sustained brand investment.
For NZ SMEs, a2's supply chain disruption and cost pressure are a reminder that even leading firms face input and logistics volatility, and smaller operators should build supply chain resilience. At the same time, the 42 percent growth in other nutritionals in China points to opportunities in adult milk powder and nutritional supplements, where NZ small and medium dairy firms could differentiate from a2 with organic, grass-fed or functional products and use the NZ-China FTA tariff advantages to enter second- and third-tier Chinese cities. They should watch the rise of local Chinese brands and regulatory change, and consider cross-border e-commerce or local channel partnerships to reduce risk.
a2's FY26 numbers also show EBITDA growth of 5.4 percent well below revenue growth of 12.4 percent, suggesting cost pressure may persist, and NZ SMEs should track global dairy input prices and logistics costs and lock in key input prices early.
Keywords: a2 Milk, FY26 results, revenue growth, infant formula, China and other Asia, EBITDA, NPAT, supply chain disruption
Photo from Unsplash (placeholder)
Source: kalkine.co.nz
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
